← 返回

TIL(肿瘤浸润淋巴细胞)和肿瘤出芽在早期口腔舌癌中的预后作用

英文原题:Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.

查看英文原题

Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.

PubMed 2021/05/06(内容时间) Laryngoscope Q2 · IF 2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

每种 TIL 亚型在口腔舌 SCC 的早期和晚期阶段可能采用不同的机制。

中文摘要

对 62 例仅接受原发灶手术治疗的早期口腔舌 SCC 患者标本进行免疫组化,检测 CD4⁺、CD8⁺、FoxP3⁺、CD45RO⁺ T 细胞及 CD163⁺ 巨噬细胞。在肿瘤实质、肿瘤间质及浸润前缘周边间质区域,分别计数各 TIL 亚型的最高数量。

多变量分析显示,肿瘤内 CD163⁺ 巨噬细胞密度高是区域控制(RC)和无病生存期(DFS)最差的预后因素。肿瘤内 CD163⁺ 巨噬细胞密度高且肿瘤芽生评分为中级或高级的患者,根据 log-rank 检验其区域控制预后较差。

不同 TIL 亚型在口腔舌 SCC 早期和晚期可能通过不同机制发挥作用。肿瘤内 CD163⁺ 巨噬细胞高密度是 RC 和 DFS 的危险因素,也可为肿瘤芽生评分中级或高级患者提供 RC 的额外分层指标。因此,在日常临床实践中识别 TIL 亚型有助于为早期口腔舌 SCC 制定更有效、个体化的治疗方案。证据等级:第 4 级。

展开英文摘要原文

Specimens from 62 patients with early oral tongue SCC treated with only primary surgery were analyzed by immunohistochemistry for CD4+, CD8+, FoxP3+, and CD45RO+ T cells and CD163+ macrophages. The highest number of each TIL subtype was counted in two areas of parenchyma and stroma in the tumor (Tumor) and peripheral stroma of the invasion margin.

Based on multivariate analysis, a high density of Tumor CD163+ macrophages served as the poorest prognostic factor for regional control (RC) and disease-free survival (DFS). Patients with both a high density of Tumor CD163+ macrophages and an intermediate- or a high-grade budding score had a poor prognosis for RC according to the log-rank test.

In summary, each TIL subtype may use different mechanisms during early and advanced stages of oral tongue SCC. A high density of Tumor CD163+ macrophages was determined to be a risk factor for RC and DFS as well as an additional stratification factor for RC in patients with intermediate- or high-grade budding scores. Therefore, identifying TIL subtypes in daily clinical practice can help determine a more successful and individualized therapeutic approach for early oral tongue SCC. LEVEL OF EVIDENCE: Step 4 (Level 4) Laryngoscope, 131:2512-2518, 2021.

论文信息

作者
Hori Y、Kubota A、Yokose T、Furukawa M、Matsushita T、Katsumata N、Oridate N
第一作者单位
Department of Otorhinolaryngology, Shinshu Ueda Medical Center, Ueda, Nagano, Japan.Japan
通讯作者单位
Department of Otolaryngology Head and Neck Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.Japan
文献类型
非美国政府资助研究
期刊
The Laryngoscope2021 Nov
原文标识
PubMed 33955550 · DOI 10.1002/lary.29589